These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 452211)

  • 1. Some characteristics of recurrent calcium stone formers in Puerto Rico.
    Benabe J; Martinez-Maldonado M
    Urology; 1979 Jul; 14(1):13-7. PubMed ID: 452211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of blood tests in screening for metabolic disorders in kidney stone disease.
    Eyre KS; Lewis F; Cui H; Grout E; Mihai R; Turney BW; Howles SA
    BJU Int; 2021 May; 127(5):538-543. PubMed ID: 32967050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal stone disease, elevated iPTH level and normocalcemia.
    Dimkovic NB; Wallele AA; Oreopoulos DG
    Int Urol Nephrol; 2002; 34(1):135-41. PubMed ID: 12549656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone in urinary stone patients.
    Khanam A; Rahman MA
    Mol Cell Biochem; 1993 Apr; 121(1):1-4. PubMed ID: 8510669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
    Parks JH; Coe FL; Evan AP; Worcester EM
    BJU Int; 2009 Mar; 103(5):670-8. PubMed ID: 18793297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological studies in hypercalciuric and normocalciuric stone formers.
    Minisola S; Scarda A; Medori C; Valtorta C; Antonelli R; Tabolli S; Rossi W; Mazzuoli G
    Urol Int; 1985; 40(2):65-71. PubMed ID: 3992738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
    Prié D; Ravery V; Boccon-Gibod L; Friedlander G
    Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism.
    Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML
    Surgery; 2012 Mar; 151(3):477-83. PubMed ID: 21893327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.
    Pak CY; Britton F; Peterson R; Ward D; Northcutt C; Breslau NA; McGuire J; Sakhaee K; Bush S; Nicar M; Norman DA; Peters P
    Am J Med; 1980 Jul; 69(1):19-30. PubMed ID: 6247914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment?
    Williams CP; Child DF; Hudson PR; Soysa LD; Davies GK; Davies MG; De Bolla AR
    J Clin Pathol; 1996 Nov; 49(11):881-8. PubMed ID: 8944605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients.
    Rendina D; Mossetti G; Viceconti R; Sorrentino M; Castaldo R; Manno G; Guadagno V; Strazzullo P; Nunziata V
    Urology; 2004 Oct; 64(4):833-8. PubMed ID: 15491743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism.
    Wikström B; Backman U; Danielson BG; Fellström B; Johansson G; Ljunghall S; Wide L
    Scand J Urol Nephrol Suppl; 1981; 61():II:1-26. PubMed ID: 6274002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary hyperparathyroidism: studies of 4,000 urinary calculi patients treated with extracorporeal shockwave lithotripsy].
    Friedrichs R; Behrendt U; Gräf K; Christians T; Borgmann V; Nagel R
    Helv Chir Acta; 1991 Sep; 58(3):327-30. PubMed ID: 1769854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and metabolic evaluation of Korean patients with urolithiasis.
    Park KJ; Jeon SS; Han DH; Lee SY
    Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones.
    Ritz E; Schmidt-Gayk H; Möhring K
    Eur Urol; 1975; 1(3):131-3. PubMed ID: 183957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal mass and serum calcitriol in male idiopathic calcium renal stone formers: role of protein intake.
    Hess B; Ackermann D; Essig M; Takkinen R; Jaeger P
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1916-21. PubMed ID: 7775641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ionized calcium and parathyroid hormone in renal stone disease.
    Muldowney FP; Freaney R; McMullin JP; Towers RP; Spillane A; O'Connor P; O'Donohoe P; Moloney M
    Q J Med; 1976 Jan; 45(177):75-86. PubMed ID: 1257401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.
    Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR
    Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.